Ai întrebări despre autism, ADHD, anxietate sau depresie? Găsești ghiduri clare, verificate de specialiști. Acum, acces gratuit.
Research demonstrates that systemic bodily inflammation alters brain function and can trigger depression-like symptoms and sickness behavior, particularly during acute infections and chronic autoimmune conditions. The study explores the biological mechanisms linking peripheral inflammation to central nervous system effects.
A randomized clinical trial from Mass General Brigham demonstrates that using personalized brain imaging to tailor transcranial magnetic stimulation (TMS) treatment may enhance outcomes for patients with treatment-resistant depression. The findings, published in JAMA Psychiatry, suggest individualized neuroimaging-guided approaches could improve the efficacy of this FDA-approved therapeutic intervention.
Olfactory and gustatory disorders are associated with significant psychological, emotional, and social distress comparable in impact to serious chronic conditions such as stroke, diabetes, and Parkinson's disease. The loss of these senses can substantially affect quality of life and mental health outcomes.
This editorial examines the intricate connections between neurocognitive disorders and depression, highlighting how these conditions frequently co-occur and influence one another. The piece addresses the clinical and research implications of understanding these interrelationships for improved patient assessment and treatment approaches.
This study identifies a genetic variant (CALHM2 V136G) that impairs ATP release from brain cells and is associated with both depression and Alzheimer's disease risk. Using engineered mouse models, researchers demonstrated that this mutation causes depressive-like behaviors and cognitive decline, which could be reversed by ATP supplementation, suggesting a novel biological mechanism linking depression to neurodegeneration.
